AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Post-LOE

amiloride hydrochloride; hydrochlorothiazide

Molecular Devices

ANDAORALTABLET

Approved

Nov 1991

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

2/8 — Basic

AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (amiloride hydrochloride; hydrochlorothiazide) by Molecular Devices. Approved for those patients with hypertension, congestive heart failure, other kaliuretic diuretics are used alone and 3 more indications. First approved in 1991.

Drug data last refreshed 18h ago

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications (6)

those patients with hypertension congestive heart failure

Worked on AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.